Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...

The firm said the FDA lifted its clinical hold on its COVID/flu combo and standalone flu vaccine resuming plans to initiate Ph3 imminently. Q3 COVID vaccine revenues missed as expected, given delayed ...

Flu and COVID-19 shots are available by appointment at BCHD ... for whom it is still being given under Emergency Use Authorization from the FDA, the vaccine decreases the risk of hospitalization and ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

The U.S. vaccine maker now expects between $175 ... including an experimental COVID-flu combination shot, which Novavax said ...

NovaVax Inc.’s stock NVAX tumbled 7% early Tuesday, after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue. The company ...

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...

today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug (IND) application, ARCT-2304, a ...

Novavax (NVAX) announced that the U.S. FDA has removed the clinical hold on Novavax’s Investigational New Drug application for its ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.